Scholar : ΜΕΝΙΕΡΕ - νέα αποτελέσματα

[PDF] Evaluation of Adding Lidocaine to Dexamethasone in the Intra-tympanic Injection for Management of Tinnitus: A Prospective, Randomized, Controlled Double-blinded …

S Elzayat, S Ragab, M Eisa, M Amer, MF Mandour… - International Tinnitus …, 2018

… This treatment could be used in many inner ear disorders like a
sensory-neural hearing loss, Meniere's disease, tinnitus associated with
these disorders, and idiopathic tinnitus9 … 2013;15 (63):83-90. 6. Barrs DM …

In vivo assay of the potential gadolinium‐induced toxicity for sensory hair cells using a zebrafish animal model

YC Rah, EJ Han, S Park, J Rhee, S Koun, HC Park… - Journal of Applied …, 2018

… Visualization of endolymphatic hydrops with MR imaging in patients with Meniere's disease
and related pathologies: current status of its methods and clinical signifi- cance …
Visualization of endolymphatic hydrops in patients with Meniere's disease …

Local Drug Delivery to the Inner Ear: Principles, Practice, and Future Challenges

SK Plontke, AN Salt - 2018

… terms will lead to slight changes in absolute numbers in the histogram, a
rapid growth in publications per year is apparent since the mid 1990's, when
local gentamicin therapy, pioneered by Lange (1989), became widely …

Головокружение при вестибулярном нейроните: подходы к диагностике и лечению

ВТ Пальчун, АА Макоева, АЛ Гусева - Вестник оториноларингологии, 2018

… Nat Rev a Cardiol. 2012;9(6):360-370. doi:10.1038/nrcardio.2012.45; Bumm P, Schlimok
G. T-lymphocyte subpopulations and HLA-DR antigens in patients with Bell's palsy, hearing
loss, neuronitis vestibularis, and Meniere's disease. Eur Arch Otorhinolaryngol …

Anatomical Basis of Drug Delivery to the Inner Ear

R Glueckert, LJ Chacko, H Rask-Andersen, L Wei… - Hearing Research, 2018

… Despite this knowledge derived from in vitro and in vivo animal experiments we still
lack an effective pharmacological treatment of the human inner ear to combat hearing
loss, tinnitus, Meniere's disease and vestibular deteriorations …

TYROSINE KINASE INHIBITORS

DM Goldstein, TD Owens - US Patent App. 15/578,623, 2018

… demyelinating polyneuropathy (CIDP), demyelinating neuropathies, Devic's
disease (neuromyelitis optica), experimental allergic encephalomyelitis, giant
cell arteritis (temporal arteritis), Guillain-Barre syndrome, Lambert-Eaton …

[HTML] Association of the Video Head Impulse Test With Improvement of Dynamic Balance and Fall Risk in Patients With Dizziness

TP Chang, MC Schubert - JAMA Otolaryngology–Head & Neck Surgery, 2018

This study evaluates the vestibuloocular reflex gain and change in fall risks after
administration of the video head impulse test among patients with subacute o.

IL-37 VARIANTS

M Nold, C Nold, A Ellisdon, J Whisstock - US Patent App. 15/737,204, 2018

This invention relates to polypeptides, including variants of interleukin-
37 (IL-37), and related therapeutics and compositions. The invention also
relates to the use of the polypeptides and compositi.

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

S Matsumoto, Y Hattori, M Toyofuku, S Morimoto… - US Patent App. 15/882,386, 2018

The present invention provides a compound having a lysine-specific
demethylase-1 inhibitory action, and useful as a medicament such as a
prophylactic or therapeutic agent for schizophrenia, developmen.

2, 3-DIHYDRO-4H-1, 3-BENZOXAZIN-4-ONE DERIVATIVES AS MODULATORS OF CHOLINERGIC MUSCARINIC M1 RECEPTOR

T Sugimoto, S Suzuki, H Sakamoto, M Yamada… - US Patent App. 15/735,418, 2018

The present invention provides a compound having a cholinergic muscarinic
M1 receptor positive allosteric modulator activity, which may be useful as
a prophylactic or therapeutic drug for Alzheimer's.

 

Δημιουργία λίστας των ειδοποιήσεών μου

Ακύρωση ειδοποίησης

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.